SARS COV 2 INFECTION

This is an early-stage study testing the safety and immune response of a new vaccine designed to protect against multiple coronaviruses, including COVID-19 variants and potential future threats. The study will enroll 51 healthy adults to receive two doses of the experimental vacc…

This study is testing the safety and immune response of a new COVID-19 vaccine designed to target the Omicron JN.1 variant. It will give a single booster dose to about 120 older adults and people with health conditions that put them at high risk for severe COVID-19. All participa…

This study is testing an updated COVID-19 vaccine designed for the 2025-2026 season in children aged 5 to 11 who have a medical condition that puts them at high risk for severe COVID-19. Researchers want to see how safe the vaccine is and how well it triggers an immune response. …

This study is testing an updated COVID-19 vaccine designed for the 2025-2026 virus season. It aims to check the safety and how well it triggers an immune response. The trial is enrolling 760 people aged 12 and older who are at higher risk for severe COVID-19, including all adults…

This is a clinical trial for a medical device that is not yet approved by the U.S. FDA. The purpose of the trial is to gather information about the device. The sponsor has chosen to withhold the specific details, including the device's purpose and who can participate.

This study aims to find a safe and reliable dose of the Omicron BA.5 COVID-19 virus to use in future research. Researchers will give small groups of healthy, previously vaccinated or infected volunteers a nasal spray containing the virus to see what dose causes a mild, measurable…

This large, long-term study aims to understand why some children and young adults develop lasting health problems after a COVID-19 infection, known as Long COVID or PASC. It will follow over 15,000 participants, both with and without prior infection, to identify risk factors and …

This study aims to understand the long-term health problems some people experience after having COVID-19, often called 'Long COVID.' Researchers will review the medical records of 500 adults who had COVID-19 and were treated at Vanderbilt clinics. The goal is to track recovery pa…